| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2024 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $236.45 | $1,418,726.00 | -3.7% | +30.4% | +32.1% | |
| Mar 20, 2024 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 9,912 | $15.82 | $156,816.43 | -1.9% | +50.4% | +99.5% | |
| Mar 20, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sell | 400 | $35.31 | $14,124.00 | -4.5% | -23.6% | -7.3% | |
| Mar 20, 2024 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 50,600 | $9.65 | $488,290.00 | +1.4% | +67.8% | +167.0% | |
| Mar 20, 2024 | HIMS Hims & Hers Health, Inc. | Dudum Andrew48 | Chief Executive Officer | Sell | 50,361 | $16.34 | $823,054.86 | -100% | +50.4% | +99.5% | |
| Mar 20, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 30,000 | $236.27 | $7,088,195.57 | -28.0% | +29.3% | +32.5% | |
| Mar 19, 2024 | EOLS Evolus, Inc. | Moatazedi David68 | See Remarks | Sell | 96,566 | $13.92 | $1,344,604.30 | -12.2% | -22.2% | -3.6% | |
| Mar 19, 2024 | EOLS Evolus, Inc. | Beaver Sandra67 | Chief Financial Officer | Sell | 5,672 | $13.92 | $78,978.06 | -3.5% | -22.2% | -3.6% | |
| Mar 19, 2024 | SUPN Supernus Pharmaceuticals, Inc. | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sell | 12,364 | $35.31 | $436,572.84 | -59.1% | -26.1% | -8.9% | |
| Mar 19, 2024 | EOLS Evolus, Inc. | Avelar Rui67 | See Remarks | Sell | 27,603 | $13.92 | $384,349.69 | -6.9% | -22.2% | -3.6% | |
| Mar 19, 2024 | HIMS Hims & Hers Health, Inc. | O'Keefe Lynne Chou | Director | Sell | 10,044 | $15.52 | $155,882.88 | -100% | +54.4% | +116.6% | |
| Mar 19, 2024 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 13,825 | $15.49 | $214,176.96 | -50.9% | +54.4% | +116.6% | |
| Mar 18, 2024 | LQDA Liquidia Corp | Kaseta Michael57 | CFO And COO | Sell | 12,166 | $15.82 | $192,466.12 | -1.8% | -14.3% | -5.3% | |
| Mar 18, 2024 | CBSTF Cannabist Co Holdings Inc. | Clarke Jeff | - | Buy | 100,000 | $0.26 | $26,360.00 | +6.9% | - | - | |
| Mar 18, 2024 | CBSTF Cannabist Co Holdings Inc. | Watson Derek | Chief Financial Officer | Buy | 5,000 | $0.26 | $1,300.00 | +4.5% | - | - | |
| Mar 18, 2024 | LQDA Liquidia Corp | Jeffs Roger66 | Chief Executive Officer | Sell | 28,583 | $15.82 | $452,183.06 | -3.3% | -14.3% | -5.3% | |
| Mar 18, 2024 | ALKS Alkermes Plc. | Nichols Christian Todd48 | SVP, Chief Commercial Officer | Sell | 10,417 | $28.10 | $292,739.58 | -13.6% | -9.2% | +24.8% | |
| Mar 18, 2024 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 5,000 | $0.15 | $750.00 | +0.2% | - | - | |
| Mar 18, 2024 | CBSTF Cannabist Co Holdings Inc. | Hart David James | Chief Executive Officer | Buy | 100,000 | $0.26 | $26,350.00 | +9.1% | - | - | |
| Mar 18, 2024 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 923 | $173.33 | $159,983.59 | -5.5% | +0.1% | -3.7% | |
| Mar 18, 2024 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 7,530 | $15.82 | $119,124.60 | -1.7% | -14.3% | -5.3% | |
| Mar 18, 2024 | CBSTF Cannabist Co Holdings Inc. | Channon Jesse | President | Buy | 34,300 | $0.26 | $8,918.00 | +8.1% | - | - | |
| Mar 18, 2024 | LQDA Liquidia Corp | Moomaw Scott | Chief Commercial Officer | Sell | 6,108 | $15.82 | $96,628.56 | -3.8% | -14.3% | -5.3% | |
| Mar 18, 2024 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 4,657 | $15.81 | $73,649.42 | -2.1% | -14.3% | -5.3% | |
| Mar 18, 2024 | LQDA Liquidia Corp | Schundler Russell58 | General Counsel | Sell | 8,653 | $15.82 | $136,890.46 | -0.9% | -14.3% | -5.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.